The WVU Cancer Institute is recruiting participants for an immunotherapy clinical trial for patients with metastatic melanoma or recurrent or metastatic head and neck squamous cell carcinoma. The trial will evaluate the effectiveness of the immunotherapy drug SD-101...
Provention Bio, Inc. (Nasdaq: PRVB), a clinical stage biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced that it has completed the enrollment in its Phase 2a PRINCE (PRovention Investigation in Crohn’s...
Scientists could help match cancer patients with no other treatment options to clinical trials with experimental medicines, by analysing the genetic faults in a sample of their blood, according to research published in Nature Medicine*. The researchers, funded by...
Leveraging innovative processes and technology to help tackle the industry’s toughest data challenges According to Tufts Center for the Study of Drug Development, the average time to build and release a clinical study database is more than 73 days and the average time...
Clinical trials in oncology may benefit from relying on personalized combination therapies rather than matching patients to monotherapies, according to a new analysis from the Investigation of Profile-Related Evidence Determining Individualized Cancer Therapy...
Vineti Inc., the leading software platform of record for personalized therapeutics, today announced a new partnership to advance and scale Marker Therapeutics’ T cell therapy pipeline. Marker Therapeutics is a clinical-stage immuno-oncology company specializing in the...
Email
Text